Resident Presentations

 

We our proud of our residents' research efforts and encourage them to submit their scholarly work to scientific meetings. The department covers travel expenses for residents to attend approved national conferences.

2019

  • Jacobs C, Barak I, Jung SH, Rocke D, Kahmke R, Suneja G, Mowery YM. Prediction Model to Estimate Overall Survival Benefit of Postoperative Radiotherapy for Resected Major Salivary Gland Cancers. Oral presentation and monetary award for best clinical and population science abstract at Duke Cancer Institute Scientific Retreat. 2019 Oct 25; Durham, NC.
  • Jacobs C, Barbour AB, Suneja G, Williamson H, Floyd SR, Torok JA, Kirkpatrick JP. Whole Brain Radiotherapy Practice Patterns in the Era of Stereotactic Radiosurgery. Digital poster presentation at American Society for Radiation Oncology (ASTRO) 61st Annual Meeting. 2019 Sept 17; Chicago, IL.
  • Jacobs C, Kahmke R, Rocke D, Barak I, Jung SH, Suneja G, Mowery YM. Nomogram to Predict Survival Benefit of Postoperative Radiotherapy for Major Salivary Gland Cancers. Oral presentation at American Society for Radiation Oncology (ASTRO) 61st Annual Meeting. 2019 Sept 17; Chicago, IL.
  • Jacobs C, Gao J, Wang X, Mehta K, Salama JK, Torok JA, Kelsey CR. Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early Stage Non-Small Cell Lung Cancer. Poster presentation at IASLC World Congress on Lung Cancer. 2019 Sept 8; Barcelona, Spain.
  • Jacobs C, Woldemichael K, Williamson H, Abisheva Z, Howell E, Abdelgadir J, Dechant C, Floyd SR, Fecci P, Kirkpatrick JP, Adamson J, Torok JA. Single- Versus Multi-Fraction Stereotactic Radiosurgery for Brainstem Metastases. Poster presentation at the Society for Neuro-Oncology’s Inaugural Conference on Brain Metastases. 2019 Aug 16; New York, NY.
  • Jacobs C, Chodavadia P, Wang F, Havrilesky L, Chino JP, Suneja G. United States Practice Patterns and Comparative Effectiveness of GOG 249 Arms. Oral presentation at American Brachytherapy Society (ABS) Annual Meeting. 2019 Jun 15; Miami, FL.
  • Jacobs C, Suneja G, Barak I, Mehta K, Agassi A, Brizel DM, Mowery YM. Utilization of Brachytherapy for Early Stage Oral Cavity Cancers in the United States. Oral presentation at American Brachytherapy Society (ABS) Annual Meeting. 2019 Jun 13; Miami, FL.
  • Barbour AB, Jacobs C, Suneja G, Floyd SR, Torok JA, Kirkpatrick JP. U.S. Radiotherapy Practice Patterns for Brain Metastases in the Era of Stereotactic Radiosurgery. Oral presentation at International Stereotactic Radiosurgery Society Congress. 2019 Jun 10; Rio de Janeiro, Brazil.
  • Jacobs C, Woldemichael K, Abisheva Z, Abdelgadir J, Howell E, Dechant C, Floyd SR, Torok JA, Adamson J, Fecci P, Kirkpatrick JP. Stereotactic Radiosurgery in 1-5 Fractions for Brainstem Metastases: Radiobiologic Rationale and Logistics Informing Clinical Practice. Poster presentation at International Stereotactic Radiosurgery Society Congress. 2019 Jun 9; Rio de Janeiro, Brazil.
  • Hong JC, Hauser ER, Redding TS, Sims KJ, Gellad ZF, O'Leary M, Madison A, Qin X, Weixx DG, Bullard AJ, Williams CD, Sullivan B, Lieberman DA, Provenzale D. Characterization of temporal relationships of comorbidities developed following cancer diagnoses in veterans (Abstract). American Society of Clinical Oncology Annual Meeting, Chicago, June 2019.
  • Chino F, Stephens SJ, Price J, Salama J. Increasing Radiation Knowledge in non-Radiation Oncologists: Improving Multidisciplinary Cancer Care Through Radiation Oncology Education Project. ROECSG Spring Symposium, Chicago, May 2019.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. Florida Socitty of Clinical Oncology, Spring Session, Orlando, FL, Apr 2019.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. North Carolina Survivorship Summit, Raleigh, NC, Apr 2019.
  • Jacobs C, Rocke D, Kahmke R, Williamson H, Suneja G, Mowery YM. Adjuvant Radiotherapy is Associated with Improved Overall Survival for Resected Alveolar Ridge Squamous Cell Carcinoma with Adverse Pathologic Features. Poster presentation at National Comprehensive Cancer Network (NCCN) Annual Conference. 2019 Mar 22; Orlando, FL.
  • Jacobs C, Gao J, Wang X, Ready NE, Clarke JM, Tong B, Kelsey CR, Suneja G, Torok JA. Definitive Radiotherapy for Inoperable Stage IIB Non-Small Cell Lung Cancer: Patterns of Care and Comparative Effectiveness Analyses Using the National Cancer Database. Poster presentation at Multidisciplinary Thoracic Cancers Symposium. 2019 Mar 14; San Diego, CA.
  • Jacobs C, Trotter J, Palta M, Wu Y, Willett CG, Lee WR, Czito BC. Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers. Poster presentation at Genitourinary Cancers Symposium. 2019 Feb 14; San Francisco, CA.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. Kansas Cancer Partnership, Topeka, Kansas. Jan 2019.

2018

  • Brownstein J, Wisdom A, Mower Y, Castle K. Lee CL, Luo L, Williams N, Ma Y, Da Silva-Campos L, Kirsch D. Calculating the RBE of carbon ion radiotherapy in a primary mouse model of sarcoma. International symposium on ion therapy (oral presentation). November 2018.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. 19th Annual Meeting of the Society of Urologic Oncology, Phoenix, AZ. November 2018.
  • Hong JC, Hauser ER, Redding TS, Sims K, Gellad Z, O’Leary M, Hyslop T, Madison A, Qin X, Weiss D, Bullard AJ, Thomas R, Williams C, Sullivan B, Johnson M, Turner M, Lieberman D, Provenzale D. Network analysis of chronological relationships of comorbidities in veterans from a prospective screening colonoscopy trial (Poster presentation). American Medical Informatics Association (AMIA) 2018 Annual Symposium, San Francisco, November 2018.
  • Hong JC, Niedzwiecki D, Palta M, Tenenbaum JD. Natural language processing to identify patient symptoms during and prior to cancer therapy (Poster presentation). American Medical Informatics Association (AMIA) 2018 Annual Symposium, San Francisco, November 2018.
  • Hong JC, Willett CG. Rectal Cancer with Synchronous Metastasis. 2018 Gastrointestinal Oncology Conference. International Society of Gastrointestinal Oncology. Arlington, VA. November 2018.
  • Jacobs C, Carpenter DJ, Chino JP. Changes on Mid-Treatment FDG-PET/CT for Cervical Cancer Treated with Chemoradiotherapy Are Associated with Prognosis. Oral presentation at American Society for Radiation Oncology (ASTRO) 60th Annual Meeting. 2018 Oct 24; San Antonio, TX.
  • Jacobs C, Carpenter DJ, Hong JC, Chino JP. Inclusion of Subjects with Internally Inconsistent or Anomalous Data within the National Cancer Database Significantly Alters Survival Results. Oral presentation at American Society for Radiation Oncology (ASTRO) 60th Annual Meeting. 2018 Oct 24; San Antonio, TX.
  • Chino F, The Impact of the Affordable Care Act on Cancer Care for Underserved Communities: The Good, The Bad, and the Unknown. 60th Annual Meeting of the American Society for Radiation Oncology, San Antonio. October 2018.
  • Hong J, Niedzwiecki D, Palta M, Tenenbaum J. Predicting emergency visits and hospital admissions in radiation and chemoradiation: Performance of a pre-treatment machine learning algorithm on different disease sites in an internal validation cohort (Oral presentation). 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO), San Antonio. October 2018.
  • Chino F, Kamal A, Chino J. Opioid-associated deaths in patients with cancer: A population study of the opioid epidemic over the past 10 years. ASCO Quality Care Symposium, Phoenix. Sept. 2018.
  • Chino F, Health Services Research: Finanical Toxicity and Cancer Treatment in America. Iowa Oncology Society, Annual Conference, Iowa City, IA, Sept. 2018.
  • Chino F, Kamal A, Chino J, LeBlanc T. Comprehensive evaluation of place of death for patients with hematological malignancies, 1999-2015. Poster presentation at American Society of Clinical Oncology Annual Meeting, Chicago, June 2018.
  • Hong J. A Learning Healthcare System: Machine Learning-Based Clinical Decision Tools (Oral presentation). American Association of Physicists in Medicine (AAPM) Practical Big Data Workshop 2018. Ann Arbor. June 2018.
  • Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK. Improved Survival of Small Cell Lung Cancer in the Veterans Health Administration from 2000-2010: Association with Increasing Utilization of PET Staging (Abstract). American Society of Clinical Oncology Annual Meeting, Chicago. June 2018.
  • Hong JC, Havrilesky LJ, Chino JP. High Volume Providers and Brachytherapy Practice: An Analysis of the Medicare Provider Utilization and Payment Data Set (Oral presentation). American Brachytherapy Society 2018 Annual Meeting, San Francisco. June 2018.
  • Spiegel D, Chino F, Moss H, Zafar Y, Havrilesky L, Chino J. "Changes in Insurance Coverage for Cancer Patients Receiving Brachytherapy Before and AFter Enactment of the Affordable Care Act". American Brachytherapy Society Annual Conference, San Francisco. June 2018.
  • Sullivan B, Redding T, Hauser ER, Gellad Z, Qin X, Weiss D, O’Leary M, Madison A, Bullard J, Hyslop T, Sims K, Thomas R, Williams C, Hong J, Johnson M, Turner M, Provenzale D, Lieberman D. Missed Lesions and Appropriate Follow-Up of Screening and Surveillance (Oral presentation). Digestive Disease Week 2018, Washington, DC. June 2018.
  • Chino, F. “Financial Toxicity and Cancer Treatment”. Indiana Oncology Society Annual Conference, Indianapolis, IN. April 2018.
  • Spiegel DY, Hong JC, Oyekunle T, Lee WR, Koontz BF, Salama JK. A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer (Oral presentation). European Society for Radiotherapy and Oncology (ESTRO) 37, Barcelona. April 2018.
  • Hong JC, Palta M, Tenenbaum JD. Machine learning on EHR data for prediction of emergency visits and hospitalization during cancer radiotherapy (Poster presentation). American Medical Informatics Association (AMIA) 2018 Informatics Summit, San Francisco, March 2018.
  • Spiegel D, Boyer M, Hong JC, Williams CD, Kelley MJ, Rangwala FA, Salama JK, Palta M. Role of Adjuvant Chemotherapy Following Chemoradiation and Surgery for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis (Poster presentation). 2018 Gastrointestinal Cancers Symposium, San Francisco. January 2018.

2017

  • Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Salama JK, Palta M. Nonoperative Management for Locally Advanced Rectal Cancer in the Veterans Health Administration. Accepted for the Best of ASTRO Meeting. 2017 Nov 10-11; Miami, FL. Presentation #144.
  • Chino F, Suneja G, Moss H, Zafar Y, Havrilesky L, Chino J. “Healthcare Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status after Medicaid Expansion under the Affordable Care Act.”. 5th Annual Duke Cancer Institute Scientific Retreat, Durham. 2017 Oct. 27. [Platform Presentation]
  • Brownstein JM, Wisdom A, Mowery Y, Castle K, Rusek A, Luo L, Williams N, Guida P, Ma Y, Lee CL, Da Silva Campos L, Kirsch D. Duke Cancer Institute. Calculating the RBE of carbon ion radiotherapy in a primary mouse model of sarcoma. Radiation Research Annual Conference (2017 poster). October 2017.
  • Ackerson BG, Hong JC, Kelsey CR. SBRT Versus Sublobar Resection for Stage I NSCLC (Poster presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Brownstein JM, Rusek A, Rossalot R, Castle K, Mowery Y, Wisdom A, Williams N, Luo L, Kirsch D. Duke Cancer Institute, ASTRO Conference (2017) High LET carbon ion radiotherapy in the treatment of a primary mouse sarcoma model at the NASA Space Research Laboratory. ASTRO annual meeting (2017 poster). September 2017.Chino F, Castellar E, Schild M, Blitzblau R, Suneja G, Duffy E, Broadwater G, Horton J Pathologic Response and Acute Toxicity: Planned Interim Analysis of the Phase II NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiotherapy in Early Stage Breast Cancer. (Poster presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego. September 2017.
  • Chino F, Hong J, Torok J, Chino J, Suneja G. IMRT Utilization Rates for Treatment of Intact Cervical Cancer, A National Cancer Database Analysis (Poster presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Chino F, Suneja G, Moss H, Zafar Y, Havrilesky L, Chino J. Healthcare Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status after Medicaid Expansion under the Affordable Care Act. (Oral Presentaton, Late Breaking Abstract Session). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego. September 2017.
  • Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. Predicting for Long-term Survival in Oligometastatic Patients treated with Ablative Radiotherapy: A Multi-institutional Pooled Analysis (Electronic poster discussion). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Jacobs C, Hong JC, Havrilesky L, Sosa JA, Chino JP. Quality of reported radiation data as recorded in the NCDB for node positive uterine cancer. Poster presented at American Society for Radiation Oncology (ASTRO) 59th Annual Meeting. September 2017; San Diego, CA.
  • Lafata K, Cai J, Wang C, Hong J, Kelsey C, Yin FF. Sensitivity of Radiomic Features to Acquisition Noise and Respiratory Motion (Oral presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Spiegel DY, Boyer MJ, Hong JC, Kelley M, Salama JK, Palta M. Non-operative Management for Locally Advanced Rectal Cancer in the Veterans Affairs System (Oral presentation). 59th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, September 2017.
  • Tandberg DJ, Cui Y, Hong JC, Ackerson B, Czito B, Willett CW, Palta M. Intra-treatment FDG-PET Imaging to Predict Radiation Induced Esophagitis during Chemoradiotherapy for Esophageal Cancer. Accepted poster presentation, 59th annual meeting American Society of Radiation Oncology, San Diego, September 2017.
  • Tandberg DJ, Lee WR, Salama J, Koontz B. Toxicity and Biochemical Outcomes of Hypofractionated Intensity Modulated Post-Operative Radiation Therapy for Prostate Cancer. Accepted poster presentation, 59th annual meeting American Society of Radiation Oncology, San Diego, September 2017.
  • Lafata K, Cai J, Wang C, Hong J, Kelsey C, Yin FF. Sensitivity of Radiomic Features to Acquisition Noise and Respiratory Motion (Oral presentation). American Association of Physicists in Medicine 2017 Meeting. August 2017.
  • Mowery YM. Impact of Mutational Load and Tumor Transplantation on Response to Radiotherapy and Immune Checkpoint Inhibitors. 2017 Immunotherapy Workshop, Incorporating Radiation Oncology into Immunotherapy. Oral presentation. Co-Sponsored by American Society for Radiation Oncology (ASTRO), National Cancer Institute (NCI) and Society for Immunotherapy of Cancer (SITC). June 15, 2017. Bethesda, MD.
  • Yin FF, Lafata K, Hong JC, Kelsey CR. Effects of Motion on Radiomics Analysis of Thoracic Cancers. Multidisciplinary Thoracic Cancers Symposium, San Francisco. March 2017.
  • Jacobs C, Jafari ME. How Low is Low? Radiation Dose Assessment of Low Dose Chest Computed Tomography for Lung Cancer Screening. Poster presented at American College of Radiation Oncology (ACRO) Annual Meeting. 2017 March 11; Orlando, FL.
  • Jacobs C, Loudas N, Driscoll C. Toxicity Analysis of Lung Stereotactic Body Radiation Therapy (SBRT) at a Community Hospital. Poster presented at American College of Radiation Oncology (ACRO) Annual Meeting. 2017 March 11; Orlando, FL.
  • Gilmore BF, Sun Z, Adam MA, Spiegel DY, Ezekian B, Turner MC, Nag U, Palta M, Migaly J, Mantyh C. IMRT is Superior to 3D-CRT for the Treatment of Anal Cancer. 12th Annual Academic Surgical Congress. 2017 February 7-9; Las Vegas, NV. Abstract #ACS20170492.
  • Spiegel, DY, Hong JC, Lee WR, Salama JK. A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer (Poster presentation). 2017 Genitourinary Cancers Symposium, Orlando. February 2017.
  • Tandberg DJ, Hong JC, Cui Y, Ackerson BG, Czito BG, Willett CW, Palta M. Interim FDG-PET imaging during neoadjuvant chemoradiotherapy for esophageal cancer: Correlation with pathologic response. Poster presentation, 2017 Gastrointestinal Cancers Symposium, San Francisco, January 2017.

2016

  • Mowery YM, Kent CL, Wisdom AJ, Van Mater D, Castle KD, Luo L, Reinsvold M, Ma Y, Reddy A, Dave S, Kirsch DG. Evaluating the impact of tumor mutational load on response to immune checkpoint inhibition and radiotherapy in primary mouse models of soft tissue sarcoma. Oral presentation. Radiation Research Society (RRS) Annual Meeting. October 16, 2016. Waikoloa Village, HI.
  • Mowery YM, Patel K, Olson AC, Khan MK, Salama JK, Salama AK. Toxicity and Survival for Metastatic Melanoma Patients Treated with Anti-PD1 Therapy and Radiation Treatment. American Society for Radiation Oncology (ASTRO) Annual Meeting. Oral presentation. September 28, 2016. Boston, MA.
  • Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito B, Hopkins MB, Palta M. Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States. ePoster session. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 27, 2016. Boston, MA.
  • Jacobs C, Borgert A, Jafari ME. Early Results of Lung Cancer Screening by Low-Dose Computed Tomography at a Community Hospital. Poster presented at American Society for Radiation Oncology (ASTRO) 58th Annual Meeting. 2016 September 26; Boston, MA.
  • Kent CL, Mowery YM, Wisdom AJ, Van Mater D, Castle KD, Reddy A, Dave SS, Kirsch DG. Immune Checkpoint Inhibition and Radiation Therapy in 2 Primary Mouse Models of Soft Tissue Sarcoma: Impact of Tumor Mutational Load. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Kent CL, Mowery YM, Wright AO, Kim GJ, Desjardins A, Peters KB, Vlahovic G, Friedman HS, Cummings TJ, McLendon RE, Friedman AH, Sampson JH, Kirkpatrick JP. Long-Term Outcomes for Patients with Atypical or Malignant Meningiomas Treated with Radiation Therapy: A Single-Institution Retrospective Analysis. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Olson AC, Patel K, Mowery YM, Wynne J, Ready N, Kirkpatrick JP, Salama AK, Khan MK. Anti-PD-1 Therapy and Stereotactic Radiation for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: A 2-Institution Series. American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Mowery YM, Vergalasova I, Yoo DS, Limon D, Das SK, Hara WY, Brizel DM. 18F-FDG PET/CT Response at 20 Gy Predicts Treatment Outcome for Head and Neck Squamous Cell Carcinoma (HNSCC). American Society for Radiation Oncology (ASTRO) Annual Meeting. September 26, 2016. Boston, MA.
  • Spiegel DY, Marcom PK, Peterson B, Force J, Howie L, Palta M, Blitzblau R, Horton J. Acute toxicity in patients with HER2-positive breast cancer treated with adjuvant radiotherapy and concurrent trastuzumab and pertuzumab. Poster #2023. 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology. September 26, 2016. Boston, MA.
  • Boyer MJ, Williams CD, Kelley MJ, and Salama JK. Improved Survival with Stereotactic Body Radiation Therapy (SBRT) Compared to Conventional Radiation in Stage I NSCLC: A Veteran’s Affairs Central Cancer Registry (VACCR) Study. Oral Presentation. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 2016.
  • Boyer MJ, Rushing C, Peterson B, Papagikos MA, Kiteley R, and Lee WR. Toxicity and Quality of Life Report of a Phase II Study of Stereotactic Body Radiotherapy (SBRT) for Low and Intermediate Risk Prostate Cancer. Poster Presentation American Society for Radiation Oncology Annual Meeting, Boston, MA, September 2016.
  • Chino F, Peppercorn J, Rushing C, Samsa G, Nicolla J, Altomare I, Zafar SY. “Going for Broke”: Out of Pocket Costs, Financial Distress and Patient-reported Willingness to Pay and Sacrifice in Cancer Care Accepted for Presentation at the American Society for Radiation Oncology Annual Meeting, Boston, MA. September 2016. [Oral Presentation].
  • Hong JC, Eng J, Faught A, Higgins K, Cui Y, Yin FF, Das S, Czito B, Willett C, Palta M. Interim FDG-PET imaging during chemoradiation for squamous anal canal carcinoma (Poster presentation). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. September 2016.
  • Hong JC, Foote J, Broadwater G, Sosa J, Gaillard S, Havrilesky L, Chino J. Total treatment duration for cervical cancer: Is 55 days still the goal in the era of concurrent chemotherapy? (Oral presentation). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. September 2016.
  • Hong JC, Gross CP, Shafman T, Hu X, Yu J, Ross R, Finkelstein S, Dosoretz A, Park H, Soulos P, Evans S. Modern Radiotherapy for Left –Sided Breast Cancer: An Analysis of Mean Heart Dose within Diverse Practice Settings (ePoster discussion). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. September 2016.
  • Martella AP, Hong JC, Foote J, Havrilesky LJ, Gaillard S, Chino JP. Chemotherapy and radiotherapy in stage III endometrial cancer and the impact of time to treatment initiation: A National Cancer Data Base study (Poster presentation). 58th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston. Setpember 2016.
  • Tandberg DJ, Cahill J, Kelsey CR. Biological Predictors of Radiation Esophagitis in Locally-Advanced Lung Cancer: A Secondary Analysis from a Prospective Study. Poster presentation, 58th annual meeting American Society of Radiation Oncology, Boston, September 2016.
  • Loman K, Nawrocki J, Hoang J, Yoo D, Chang Z, Mowery Y, Li X, Peterson B, Brizel D, Craciunescu O. Establishing Relevant ADC-Based Texture Analysis Metrics for Quantifying Early Treatment-Induced Changes in Head and Neck Squamous Cell Carcinoma. American Association of Physicists in Medicine Annual Meeting. August 1, 2016. Washington, DC.
  • Olson AC, Craciunescu O, Meltsner S, Cai J, Cheng JZ, Chino JP. Dosimetry, Feasibility, and Acute Toxicity of Combined Intracavitary Brachytherapy and Free-Hand Interstitial Needle Placement for Locally Advanced Cervix and Uterine Cancer. World Congress of Brachytherapy; 2016 June 27-29; San Francisco, CA. Oral Presentation.
  • Hong JC, Foote J, Havrilesky LJ, Gaillard S, Chino JP. Chemotherapy and radiotherapy in early stage uterine papillary serous and clear cell carcinoma: A National Cancer Data Base study (Poster presentation). 2016 ASCO Annual Meeting, Chicago. June 2016.
  • Schroeder K, Olson AC, Ackerson B, Larrier NL, Masalu N, Chao N, Likonda B. Radiation needs in pediatric oncology in the lake region of Tanzania. Symposium on Global Cancer Research, CUGH Annual Conference. 2016 April; San Francisco, CA. Poster Presentation.
  • Cramer CK, Yoon SW, Reinsvold M, Joo KM, Norris H, Hood RC, Adamson JD, Klein RC, Kirsch DG, Oldham M. Treatment planning and delivery of whole brain irradiation with hippocampal avoidance in rats. 3rd Symposium on Small Animal Precision Image-Guided RadioTherapy, Ghent, 2016 March 21-23.
  • Mowery YM, Vergalasova I, Limon D, Yoo DS, Das SK, Hara WY, Brizel DM. Intra-treatment 18F-FDG-PET/CT as an Imaging Biomarker for Head & Neck Caner. 2016 Radiation Oncology & Imaging Program Annual Retreat. March 14, 2016. Durham, NC.
  • Mowery Y, Craciunescu O, Light K, Chino J. Incorporating a color-coded graphical interface into radiation treatment planning software to improve safety for patients undergoing external beam pelvic radiotherapy for gynecologic malignancies. 11th Annual Duke Health Patient Safety and Quality Conference. March 10, 2016. Durham, NC.
  • Mowery YM, Vergalasova I, Yoo DS, Das SK, Hara WY, Brizel DM. Correlating Clinical Outcomes with Changes in Tumor Volume and 18F-FDG PET Characteristics during Radiotherapy (RT) for Head and Neck Squamous Cell Carcinoma (HNSCC). Poster #227. 2016 Multidisciplinary Head and Neck Cancer Symposium. February 18, 2016. Scottsdale, AZ.
  • Tumati V, Jacobs C, Ying J, Roehrborn CG, Lotan Y, Margulis V, Pistenmaa D, Kim DW, Hannan R. Outcomes in high-risk prostate cancer patients treated with definitive versus adjuvant radiation therapy. Poster presented at American Society of Clinical Oncology Genitourinary Cancer Symposium. 2016 January 9; San Francisco, CA.

2015

  • Qin R, Singh B, Olson AC, Bhavsar N, Wolf S, Salama JK, Kirkpatrick JP, Salama AK. Safety and efficacy of radiation in advanced melanoma patients treated with ipilimumab. Society for Melanoma Research 2015 Congress. 2015 November 18-21, San Francisco, CA. Poster Presentation.
  • Mowery Y, Kim G, Wright A, Desjardins A, Peters K, Vlahovic G, Friedman H, Sampson J, Kirkpatrick J. Outcomes for Patients With Intracranial Meningiomas Treated With Radiation therapy and Bevacizumab: A Single-Institution Retrospective Analysis. Poster #2265. American Society for Radiation Oncology (ASTRO) 2015 Annual Meeting. October 19, 2015. San Antonio, TX.
  • Mowery Y, Vergalasova I, Yoo D, Das S, Brizel D. Correlating Outcomes With Changes in Tumor Volume and 18F-FDG PET Characteristics During Radiation Therapy for Head and Neck Squamous Cell Carcinoma (HNSCC). Poster #2835. American Society for Radiation Oncology (ASTRO) 2015 Annual Meeting. October 19, 2015. San Antonio, TX.
  • Olson AC, Qin R, Singh B, Bhavsar N, Wolf S, Salama JK, Kirkpatrick JP, Salama AK. Radiosurgery for Brain Metastases in Melanoma Patients Receiving Ipilimumab. ASTRO Annual Meeting; 2015 October 18-21; San Antonio, TX. Poster Presentation.
  • Robinson TJ, Zhang M, Kirsch DG. Next Generation Sequencing of Sarcoma Cells with HIF-1a Deletion Reveals Context-Dependent Regulation of HIF-1 Transcriptional Targets Induced by Radiation vs. Hypoxia. ASTRO 2015. October 2015. [electronic poster and short podium presentation].
  • Torok JA, Castle KD, Reinsvold M, Kirsch DG. Modulation of endothelial cell radiation sensitivity and lung tumor response to radiation therapy. Poster and oral presentation at the American Society of Therapeutic Radiation Oncology 2015 Annual Conference. October 2015.

2014

  • Cramer CK. The Role of Radiotherapy in Retroperitoneal Sarcoma. Presentation to the Sarcoma Group at Duke University Hospital. December 16, 2014.
  • Mowery YM, Greenup RA, Houck K, Palta M, Horton JK, Sosa JA, Hwang ES, Blitzblau RC. Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US. San Antonio Breast Cancer Symposium. December 2014. San Antonio, TX.
  • Mowery Y, Wright A, Desjardins A, Peters K, Ranjan T, Vlahovic G, Friedman H, Zomorodi A, Kaylie D, Adogwa O, Nimjee S, Sperduto W, Chagoya G, Fatemi P, McLendon R, Cummings T, Friedman A, Sampson J, Kirkpatrick J. Long-term outcomes for patients with intracranial meningiomas: a single-institution retrospective analysis. Poster MS-19. Society for Neuro-Oncology 2014 Annual Meeting. November 14, 2014. Miami, FL.
  • Boyle J, Dorth, Craciunescu O, Steffey B, Light K, Chino J. Simultaneous Integrated Boost to Pelvic and Paraaortic Nodes from Cervical Cancer Improves the Dosimetric Therapeutic Ratio [abstract]. In: American Society for Radiation Oncology Annual Meeting 2014. September 14-17; San Francisco, CA; Fairfax, VA: ASTRO; 2014.
  • Boyle J, Smoking History Predicts for Increased Risk of Second Primary Lung Cancer: A Comprehensive Analysis, American Society of Radiation Oncology (ASTRO) Annual Meeting Oral Presentation- September 14-17, 2014, San Francisco, CA.
  • Olson AC, Das S, May R, Czito B, Kelsey C, Patel P. Normal Tissue Toxicity Risk Assessment with Interim 18F-FDG PET-CT in Patients with Non-Small Cell Lung Cancer Undergoing Radiotherapy. ASTRO Annual Meeting; 2014 Sept 14-17; San Francisco, CA. Poster Presentation.
  • Mowery Y, Vergalasova I, Pura J, Peterson B, Yoo D, Das S, Brizel D. Changes in Tumor Volumes and 18F-FDG PET characteristics during Radiotherapy for HPV+ and HPV- Head and Neck Squamous Cell Carcinoma (HNSCC). Poster #2886. American Society for Radiation Oncology (ASTRO) 2014 Annual Meeting. September 2014. San Francisco, CA.
  • Robinson TJ, Dewhirst M, Chi JT. Hypoxia induces mRNA 3'UTR truncation in multiple cell types in vitro. ASTRO 2014 [poster presentation]. September 2014.
  • Tandberg DJ, Kelsey CR, Berry MF. Invasive sampling of PET positive aortopulmonary window lymph nodes in patients with right-sided non-small cell lung cancer is not always necessary to guide treatment. Poster presentation, 56th annual meeting American Society of Radiation Oncology, San Francisco, September 2014.
  • Torok JA, Wu Y, Prosnitz LR, Kim G, Beaven AW, Diehl LF, Kelsey CR. Low-dose consolidation radiation therapy for early-stage unfavorable Hodgkin lymphoma. Poster presentation at the American Society of Therapeutic Radiation Oncology 2014 Annual Conference. September 2014.
  • Cramer CK, Palta M, Pura J, Patel P, and Brizel DM. Ipsilateral Tonsil Chemoradiation in the IMRT Era: Effective Local-Regional Control with Reduced Toxicity. Poster presentation for 2014 Multidisciplinary Head and Neck Symposium, Scottsdale, AZ, Feb 20-22, 2014.

2013

  • Boyle JM, Dorth J, Craciunescu O, Steffey B, Light K, Chino J. Initial Safety and Feasibility of Dose Escalation Using a Simultaneous Integrated Boost in Patients with Locally Advanced Gynecologic Malignancies. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Cramer CK, Chino J. Decreased Radiation Utilization During The Economic Crisis Of 2008-2009. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Lewis SL, Porceddu S, Hoskin P, Chmura S, Moghanaki D, Lo S, Palma D, Nakamura N, Salama J. An International Survey of Definitive SABR for Extra-cranial Limited Metastases. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Patel PR, Palta M, Clough R, Yoo D, Brizel DM. Reduced Volume Irradiation for Head and Neck Cancer of Unknown Primary (HNCUP). (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Perez BA, Patel PR, Yoo S, O'Neill L, Livengood KP, Catalano S, Chollet CT, Blitzblau RC. (poster presentation). Evaluating Radiation Dose to the Heart with Left Whole Breast Radiotherapy in Prone, Supine Breath Hold, and Supine Free Breathing Positions. 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Robinson TJ, Dewhirst M. Detection of Novel Hypoxia Induced Changes in Alternative mRNA Processing Associated with Clinical Prognosis in Adenocarcinoma of the Lung. (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Torok J, Kelsey C, Salama J. Patterns of Distant Metastases in Surgically Managed Early Stage Non-Small Cell Lung Cancer (poster presentation). 55th Annual ASTRO Meeting. Atlanta, Georgia. September 22-25, 2013.
  • Chino F, Peppercorn J, Tulsky J, Ubel P, Schrag D, Rushing C, Nicolla J, Altomare I, Samsa G, Abernethy A, Zafar SY. The financial burden of cancer care: Do patients know what to expect? J Clin Oncol 31, 2013 (suppl; abstr 6516). Presented at ASCO Annual Meeting, Chicago, IL. June 2013. [Poster Discussion Session]
  • Chino F, Peppercorn J, Tulsky J, Ubel P, Schrag D, Rushing C, Nicolla J, Altomare I, Samsa G, Abernethy A, Zafar SY. The financial burden of cancer care: What are patients’ attitudes toward their costs? Presented at the International Conference on Communication in Healthcare, Montreal, Canada. September 2013. [Oral Presentation].
  • Zafar SY, Abernethy A, Tulsky J, Ubel P, Schrag D, Rushing C, Chino F, Nicolla J, Altomare I, Samsa G, Peppercorn J. Financial distress, communication, and cancer treatment decision making: Does cost matter? J Clin Oncol 31, 2013 (suppl; abstr 6506). Presented at ASCO Annual Meeting, Chicago, IL. June 2013. [Oral Presentation].
  • Boyle J. Body mass index and Dosimetery of Vaginal Brachytherapy. 2013 American Brachytherapy Society (ABS) Annual Meeting. New Orleans, LA. April 18-20, 2013.
  • Boyle J. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning, American Brachytherapy Society (ABS) Annual Meeting Oral Presentation – April 18-20, 2013, New Orleans, LA.
  • Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SR. Longitudinal trends in costs of palliative radiation for Medicare beneficiaries in the last year of life who died between 2000 and 2007. ASCO 2013 and ASTRO 2013 [poster presentation].

2012

  • Boyle J. The Role of Radiation Therapy in Hodgkin Lymphoma, Resurrection Health Care Oncology Grand Rounds – December 22, 2012, Evanston, IL.
  • Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, Chang Z, Duffy E, Peterson B, Kirkpatrick JP. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S7
  • Czito B, Willett C, Palta M, Kennedy-Newton P, Uronis H. A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC), Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S42
  • Dorth JA, Prosnitz L, Broadwater G, Beaven A, Kelsey C, Radiation Therapy Dose-Response Analysis for Diffuse Large B-cell Lymphoma With a Complete Response to Chemotherapy, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S615
  • Dorth, JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma With Negative Post-Chemotherapy Radiologic Imaging, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, 1 November 2012, Pages 762-767.
  • Kelsey CR, Higgins K, Peterson B, Marks LB, Tandberg D, Chino J, DeCamp M, Varlotto J. Analysis of Prognostic Factors Affecting Local and Distant Recurrence Following Surgery for Non-small Cell Lung Cancer: A Recursive Partitioning Analysis, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S569
  • Lewis S, Vredenburgh J, Desjardins A, Peters K, Green S, Hood R, Yang Y, Sampson J, Wang Z, Kirkpatrick JP, Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Pages S266-S267
  • Oh DS, Chao HH, Balletta LD, Contreras CM, Perou CM, Radiation-induced Gene Signature Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S25
  • Palta MP, Patel P, Horton J, Blitzblau R. Use of Adjuvant Radiation Therapy in Elderly Patients With Early Stage Breast Cancer: Changes in Practice Patterns After Publication of Cancer and Leukemia Group B (CALGB) 9343, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S256
  • Patel PR, Lee J, Kundu D, Temple K, May R, Lee WR, Yoo D, Brizel DM. Postoperative Radiation Therapy for Salivary Gland Tumors: Factors Associated With Treatment Failure and Toxicity, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Pages S502-S503
  • Perez B, Vajzovic L, Mettu P, Rivera D, Alkaissi A, Steffey B, Stinnett S, Marks LB, Mruthyunjaya P, Kirsch DG, Evaluating the Relationship Between Prescription Dose and Overall Survival Among Patients Treated With I-125 Brachytherapy for Posterior Uveal Melanoma, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012, Page S197
  • Wright A, Chino J, Kelsey C. Non-small Cell Lung Cancer With Chest Wall Invasion Is Associated With High Rates of Positive Margins and Local Failure After Surgery, Int J Rad Oncol Biol Phys, Volume 84, Issue 3, Supplement, 1 November 2012.

2011

  • Kirkpatrick J. P., M. Palta. MDA Randomized Study to Determine the Optimal PTV for Radiosurgery of Brain Metastatases: A Preliminary Toxicity Review. 97th Scientific Assembly and Annual Meeting of Radiological Society of North America. November 27-December 2, 2011. Chicago, Ilinois.
  • Cramer C. Pseudoprogression in Glioblastoma Multiforme [presentation]. Oncology Grand Rounds Conference, NorthShore University HealthSystem, Evanston, IL Nov. 18, 2011.
  • Cabrera A.R. , O. Craciunescu, K.C. Cuneo, Z. Chang, J.P. Kirkpatrick. Evaluating Recurrent Gliomas with Diffusion-weighted MR Imaging Before and After Concurrent Radiosurgery and Bevacizumab. Proceedings of the American Society for Radiation Oncology 53rd Annual Meeting--Miami Beach, Florida. International Journal of Radiation Oncology Biology Physics: 81(2) 2, Supplement, 1 October 2011, Pages S793.October 2-6, 2011.
  • Cuneo K.C., A.R. Cabrera, J. Sampson, K. Allen, E. Duffy, J.J. Vredenburgh, K.B. Peters, Z. Chang, A. Desjardins, J.P. Kirkpatrick. Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S185
  • Cuneo K.C., J.K. Mito, B.E. Brigman, J.M. Ferrer, C. Lee, W.C. Eward, J.E. Carter, D.G. Kirsch. Effects of Radiation Therapy on the Detection of Microscopic Residual Cancer in the Surgical Bed using a Protease-activated Fluorescent Probe in a Primary Soft Tissue Sarcoma Model. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S729-S730
  • Dorth J.A. , D.M. Brizel Incidence of Asymptomatic Carotid Artery Stenosis in Survivors of Head and Neck Radiation. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S76.
  • Higgins K.A. , J.P. Chino, D.S. Yoo, C.R. KelseyLymphovascular Invasion in Non-small Cell Lung Cancer: Implications for Staging and Adjuvant Therapy. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S573.
  • Kelsey C.R. , J. Chino, D. Yoo, K. Higgins. Pathologic N1 Non-small Cell Lung Cancer: Identifying Subsets of Patients at High Risk of Local Failure. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S165.
  • Kirkpatrick J.P. , S. Green, T. Zagar, Z. Wang. Balancing Tumor Kill and Normal Tissue Toxicity in Radiosurgery: Critical Impact of the Peritumoral Zone. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S866.
  • Oh D.S. , H. Song, S. Freedland, L. Gerber, P. Patel, S. Lewis, D. Yoo, J. Oleson, J.K. Salama. Statin Use and Prostate Cancer Recurrence in Men Treated with Brachytherapy. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S12-S13.
  • Palta M. , R. Clough, D. Yoo, R. Scher, N. Ready, D. Brizel. Twenty Year Experience with Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of the Oropharyn. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S503-S504
  • Pepek J.M., J.P. Chino, K.A. Higgins, D.S. Yoo, C.R. Kelsey. Does SUVmax of the Primary Tumor Predict Regional Lymph Node Involvement or Local/Regional Recurrence in Resected Non-small Cell Lung Cancer? International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S581-S582
  • Pepek J.M., K.A. Higgins, J.P. Chino, D.S. Yoo, C.R. Kelsey. Accuracy of PET in Identifying Hilar (N1) Lymph Node Involvement in Non-small Cell Lung Cancer: Implications for the Radiation Oncologist. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S53
  • Yue J., J. Yu, A.R. Cabrera, X. Sun, S. Zhao, L. Ma. Measuring Tumor Hypoxia with 18F-FETNIM PET in Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Page S319
  • Zagar T.M. , M. Palta, S. Catalano, L. O′Neill, S. Yoo, P. Leonard, J. HortonDosimetric Comparison Of Radiotherapy For Left Sided Breast Cancer: Breath-hold versus Free Breathing. International Journal of Radiation Oncology Biology Physics, Volume 81, Issue 2, Supplement, 1 October 2011, Pages S780-S781.
  • Cuneo KC, Cabrera A, Sampson JH, Reardon DA, Allen KJ, Chang Z, Herndon JE, Kirkpatrick JP. Prospective Study of Radiosurgery and Bevacizumab for Recurrent Malignant Glioma. J Clin Oncol 29:2011(suppl; abstr 2082). ASCO Annual Meeting 2011. June 2011.
  • Robinson TJ, Forte E, Salinas-Mondrigan R, Puri S, Marengo M, Garcia-Blanco MA and Luftig MA. SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data. Era of Hope - Dpartment of Defense (DOD) Breast Cancer Research Program (BCRP), 2011, [poster presentation].